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Abstract: 
Driveline infections and sepsis are amongst the most common causes of 
morbidity and mortality in a patient with a left ventricular assist device.  In this 
case, we present a patient with a multi drug resistant pseudomonas aeruginosa 
driveline exit site infection.  Initially, it was treated with dual antibiotics, followed 
by surgical debridement utilizing Dakin’s solution irrigation and standard negative 
pressure wound therapy. Wound healing was minimal determined by poor 
granulation appearance, unchanged size from surgical debridement, purulent 
drainage, and the wound base remained colonized with multi drug resistant 
pseudomonas aeruginosa. A novel treatment of VeraFlo negative pressure 
wound therapy in conjunction with indwelling Dakin’s solution into the wound 
base was introduced. This treatment resulted in improved granulation 
appearance, decreased drainage, decreasing in wound size, with positive 
changes noticeable in 7 days. We suggest that the use of VeraFlo negative 
pressure wound therapy may be used for treatment for cumbersome driveline 
infections.  
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Introduction:   
Left ventricular assist device (LVAD) is indicated to provide mechanical 
circulatory support for patients with advanced heart failure as a bridge to heart 
transplantation or as a destination therapy. LVAD support has been linked to 
increased survival and quality of life amongst this patient population (1-4). The 
long term support with LVAD implant may be jeopardized by adverse events 
such as driveline infection (5).   The most common microorganisms leading to 
driveline infections are biofilm forming organisms such as staphylococcus and 
pseudomonas aeruginosa (6). Stabilization of the driveline can aid in preventing 
exit site infections (7).  Several treatments for driveline site infections have been 
suggested including but not limited to topical and systemic antibiotics, pump 
exchange, and new tunnel of the driveline exit site (6).  Vacuum Assisted Closure 
(VAC) VeraFlo Therapy (Kinetic Concepts, Inc, San Antonio, TX, USA) combines 
negative pressure wound therapy with instillation of antimicrobial solution, which 
cleanses the wound, treats the wound with antiseptic solution, and facilitates 
healing of the wound.  Instillation of the antimicrobial solution are programmed at 
set intervals which aids in loosening contaminants followed by removal of 
infectious material resulting in a lower bacterial burden (8, 9). In addition, VAC 
VeraFlo Therapy has shown that it controls wound cleansing with less 
aerosolisation compared with standard techniques. Therefore, it reduces the 
potential spread of biofilm-producing microorganisms during wound cleansing 
and environmental contamination associated with lavage (10). 
Case Report: 
A 62 year old woman with a history of a chemotherapy induced cardiomyopathy 
received a HeartWare LVAD as destination therapy. In a year, she developed 
pump thrombosis, and the LVAD was exchanged. The driveline exit site was 
alternated from the right to the left lower quadrant of the abdomen.   
Three months post implant of the new device, the patient accidentally dropped 
the controller and pulled the driveline. Several days later, she developed left 
lower quadrant pain, mild erythema, and increased mobility of the driveline 
accompanied by drainage. The driveline culture was positive for pan-susceptible 
pseudomonas. At the time of presentation, abdominal computer tomography (CT) 
revealed a fluid collection around the proximal portion of the driveline with 
inflammatory changes throughout the remainder of the driveline. Intravenous 
cefepime and oral ciprofloxacin was given for four weeks. Driveline was 
stabilized with two sutures.   
Two weeks post completion of intravenous antibiotics, the patient came to the 
emergency department with sepsis (fever, chills, tachycardia, fatigue, and 
leukocytosis).  Examination of the driveline exit site revealed left lower quadrant 
tenderness, mild erythema, serosanguinous drainage, and complete 
disincorporation of the driveline (Figure 1).   
  
 
 
The VAD Journal: http://dx.doi.org/10.13023/VAD.2015.10   Page 3 of 10 
 
The VAD Journal: The journal of mechanical assisted circulation and heart failure 
 
Figure 1: Driveline exit site   
 
The driveline exit site was re-cultured in which revealed Pseudomonas 
susceptible to cefepime, which was started.   Despite antibiotics, the abdominal 
pain was worsening. Repeat CT scan revealed abscess involving the entire 
length of the driveline.  The patient was taken to the operating room for wound 
debridement. Surgical removal of infected tissue, wash out with Dakin’s solution, 
instillation of cefepime powder and pneumovac with continuous negative 
pressure and standard black foam was placed. The wound measured  abscess 
was found to be more involved then what the CT scan results showed, with 
wound measurements (17cm (length) x 7cm (width) x 5cm (depth)) incision was 
made resulting in removal of the infected tissue, (Figure 2).   
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Figure 2. Wound after surgical debridement; 17x7x5 cm 
During wound vac, dressing changes completed only by a trained ventricular 
assist devices Coordinator every 48 hours; velour of driveline was cleansed with 
topical Dakin’s solution in addition to placing cefepime powder in wound bed.    
Despite best efforts, no improvement of the wound bed occurred 26 days post 
debridement (Figure 3). The wound had same size, with the bed covered with 
purulent discharge. 
 
 
Figure 3. Wound in 26 days after surgical debridement, on intravenous 
antibiotics. Size 16x6x4 cm.  
 
VeraFlo negative pressure wound therapy with infusion was initiated on day 26 
post-debridement in which we utilized normal saline instillation into the wound 
bed. The VeraFlo dressing was changed every 48 hours.  The first VeraFlo 
dressing change prompted the team to switch the saline instillation to Dakin’s 
Infusion (65ml Infusion of Dakin’s solution with 10 minutes dwell time every 3.5 
hours). Prior to the dressing change, the wound bed was re-cultured and 
revealed a multi-drug resistant pseudomonas. Antibiotics were switched given 
sensitivities now best treated with intravenous ciprofloxacin.   
Within three days of changing to Dakin’s instillation, the wound showed signs of 
improvement as evidenced by increased granulation, lack of purulent drainage, 
improving size. VeraFlo therapy was utilized for a total of seven dressing 
changes with 14 days of Dakin’s instillation. Patient was then able to be 
transitioned back to the standard pneumovac.  Patient was able to be discharged 
home with home health nurse and pneumovac therapy in addition to Prisma AG 
collagen product being placed in wound bed.  When comparing the wound 
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measurements from day 1 post debridement to day 34, initiation of VeraFlo 
therapy with Dakin’s solution revealed the most improvement (Figure 4).  
 
Figure 4 A. Day 6 on Dakin’s solution. Size 14.8 x5.8 x 4 cm 
 
 
Figure 4 B. Day 10 on Dakin’s solution. Size 14 x5.8 x 3.8 cm 
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Figure 4 C. Day 16 on Dakin’s solution. Size 14 x4.6 x 3.5 cm 
 
 
Figure 4 D. Day 25 on Dakin’s solution. Size 14 x 4 x 3 cm 
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Figure 4 E. Day 2 after discharge. Size 14 x 4 x 2.5 cm 
 
 
 
  
Figure 4 F. Day 15 after discharge. Size 13 x 2.5 x 1.5 cm 
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Figure 4G. Day 20 after discharge. Size 11 x 1.5x 1cm 
 
Discussion 
Until LVADs become fully implantable, the driveline infection will continue to be 
one of the most common sources of morbidity and mortality in this patient 
population (6).  
Recurrent driveline trauma, tension on the wound edge, and localized hematoma 
of the pump pocket have been factors in which predispose patients to bacterial 
colonization and subsequent infection (11-14).  
Dakin’s solution consists of diluted sodium hypochlorite; i.e. household bleach 
which has broad antimicrobial activity (15). Dakin was first used as a topical 
antiseptic during World War I (16).   Currently, Dakin’s solution is available 
commercially at full strength (0.5%), half strength (0.25%, quarter strength 
(0.125%) and 1/40 strength (0.0125%) 
Vacuum assisted closure has been used frequently in the context of negative 
pressure wound therapy, which involves automated wound cleansing and 
removal of infectious materials.  VeraFlo negative pressure wound therapy 
integrates standard pneumovac with infusion of solution at a timed and 
intermittent delivery (17).  Gabriel et al. reported “a significant decrease in the 
meantime to bioburden reduction, wound closure, and hospital discharge” when 
using negative pressure wound with infusion (18).  
Previously, Raad et al. applied this therapy with Dakin’s instillation to five patients 
with venous stasis ulcers greater than 200 cm2.  Two of those patients had multi 
drug resistant pseudomonas aeruginosa as the causative organism.  All patients 
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in this study had complete wound healing at one year (19). Our case is the first to 
report the use of this therapy in patient with LVAD and driveline related infection. 
In this case, multiple modalities were utilized including intravenous antibiotics 
(cefepime and meropenum), oral antibiotic (cirprofloxacin), surgical debridement, 
topical cefepime powder with standard negative pressure wound therapy, and 
pneumovac therapy with saline instillation. All failed to improve the wound bed.  
Utilization of Dakin’s solution showed to be effective in treating large multi drug 
resistant pseudomonas aeruginosa infected wound as discussed earlier.  Our 
case supports the utilization of this therapy in LVAD-related infections.  
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